Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Table 4.

ANOVA data obtained after regression analysis and lack of fit tests for the best-fitted quadratic model for R1 (PS), R2 (%EE), and R3 (%CDR).

Model Source R1 (PS in nm) R2 (EE in %) R3 (CDR in %)
Regression analysis
Quadratic Sum of Squares 7038.21 794.48 609.69
df 9 9 9
Mean Square 782.02 88.28 67.74
F-Value 769.73 130.55 558.46
p-value, Prob > F <0.0001 <0.0001 <0.0001
Remark Suggested, significant
Lack of fit tests
Quadratic Sum of Squares 3.72 3.22 0.5223
df 3 3 3
Mean Square 1.24 1.07 0.1741
F-Value 1.82 13.09 4.14
p-value, Prob > F 0.3732 0.0718 0.2008
Remark Suggested, not significant
HHS Vulnerability Disclosure